These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33933554)

  • 1. Improving the therapeutic ratio of radiotherapy against radioresistant cancers: Leveraging on novel artificial intelligence-based approaches for drug combination discovery.
    Poon DJJ; Tay LM; Ho D; Chua MLK; Chow EK; Yeo ELL
    Cancer Lett; 2021 Jul; 511():56-67. PubMed ID: 33933554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial Intelligence in Radiation Oncology.
    Deig CR; Kanwar A; Thompson RF
    Hematol Oncol Clin North Am; 2019 Dec; 33(6):1095-1104. PubMed ID: 31668208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA repair inhibitors to enhance radiotherapy: Progresses and limitations.
    Ferreira S; Dutreix M
    Cancer Radiother; 2019 Dec; 23(8):883-890. PubMed ID: 31615730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically relevant radioresistant cell line: a simple model to understand cancer radioresistance.
    Kuwahara Y; Roudkenar MH; Urushihara Y; Saito Y; Tomita K; Roushandeh AM; Sato T; Kurimasa A; Fukumoto M
    Med Mol Morphol; 2017 Dec; 50(4):195-204. PubMed ID: 29067564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.
    Arechaga-Ocampo E; Lopez-Camarillo C; Villegas-Sepulveda N; Gonzalez-De la Rosa CH; Perez-Añorve IX; Roldan-Perez R; Flores-Perez A; Peña-Curiel O; Angeles-Zaragoza O; Rangel Corona R; Gonzalez-Barrios JA; Bonilla-Moreno R; Del Moral-Hernandez O; Herrera LA; Garcia-Carranca A
    Tumour Biol; 2017 Mar; 39(3):1010428317695010. PubMed ID: 28345453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of artificial intelligence to enhance phenotypic drug discovery.
    Malandraki-Miller S; Riley PR
    Drug Discov Today; 2021 Apr; 26(4):887-901. PubMed ID: 33484947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report.
    Thomas G; Eisenhauer E; Bristow RG; Grau C; Hurkmans C; Ost P; Guckenberger M; Deutsch E; Lacombe D; Weber DC;
    Eur J Cancer; 2020 May; 131():76-88. PubMed ID: 32305726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial Intelligence-Driven Designer Drug Combinations: From Drug Development to Personalized Medicine.
    Rashid MBMA; Chow EK
    SLAS Technol; 2019 Feb; 24(1):124-125. PubMed ID: 30249153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial Intelligence and Cancer Drug Development.
    Yang F; Darsey JA; Ghosh A; Li HY; Yang MQ; Wang S
    Recent Pat Anticancer Drug Discov; 2022; 17(1):2-8. PubMed ID: 34323201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy.
    Zaffaroni M; Vincini MG; Corrao G; Marvaso G; Pepa M; Viglietto G; Amodio N; Jereczek-Fossa BA
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiles of Radioresistance Mechanisms in Prostate Cancer.
    Chaiswing L; Weiss HL; Jayswal RD; Clair DKS; Kyprianou N
    Crit Rev Oncog; 2018; 23(1-2):39-67. PubMed ID: 29953367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing Proton Beam Therapy through Novel Insights into Tumour Radioresistance.
    Chua KLM; Chu PL; Tng DJH; Soo KC; Chua MLK
    Clin Oncol (R Coll Radiol); 2021 Nov; 33(11):e469-e481. PubMed ID: 34509347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
    Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
    Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition.
    Gomez-Casal R; Epperly MW; Wang H; Proia DA; Greenberger JS; Levina V
    Oncotarget; 2015 Dec; 6(42):44306-22. PubMed ID: 26517240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Artificial Intelligence to Improve the Quality and Safety of Radiation Therapy.
    Pillai M; Adapa K; Das SK; Mazur L; Dooley J; Marks LB; Thompson RF; Chera BS
    J Am Coll Radiol; 2019 Sep; 16(9 Pt B):1267-1272. PubMed ID: 31492404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics in radiation oncology-basics, methods, and limitations.
    Lohmann P; Bousabarah K; Hoevels M; Treuer H
    Strahlenther Onkol; 2020 Oct; 196(10):848-855. PubMed ID: 32647917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodological Development of Combination Drug and Radiotherapy in Basic and Clinical Research.
    Chargari C; Levy A; Paoletti X; Soria JC; Massard C; Weichselbaum RR; Deutsch E
    Clin Cancer Res; 2020 Sep; 26(18):4723-4736. PubMed ID: 32409306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial intelligence in radiation oncology: A review of its current status and potential application for the radiotherapy workforce.
    Parkinson C; Matthams C; Foley K; Spezi E
    Radiography (Lond); 2021 Oct; 27 Suppl 1():S63-S68. PubMed ID: 34493445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.